For the second week in a row my worst performing share was IQE:IQE, dropping 8% in my SIPP and 27% in my ISA. Not the disaster of last week, and still up by 245% but far from the 400% gains a few weeks ago. I know the right thing to do is hold and not look at the price fluctuations, but it's so frustrating knowing that people are making huge amounts of money from those fluctuations - and in my opinion manipulating the share price to ensure they do!
Next worst performer was my newest share BLU:Blue Star Capital, dropping 6% and now 32% down in 2 weeks - that was a well timed purchase! Fortunately I only dipped a toe with £500 while I get a handle on the whole crypto-currency thing. I think the best potential here is a reverse takeover of Satoshipay. This has massive potential for revolutionising the presentation of paid content and BLU:Blue Star Capital have around 30% stake so would be a good vehicle for Satoshipay to go public.
OPTI:Optibiotix fell yet again by 2p which did £900 damage. My "bargain" purchase last week at 66p doesn't look like such a bargain now you can buy them for 62p. Very frustrating reading the bulletin board where people are happily announcing they are back in the share at 62p while I've seen nothing for my 2 years holding and am losing £3,237. I really, really hope something comes of the SBTX:SkinBiotherapeutics free shares for long term holders. There's surely got to be some reward for supporting this company for so long.
I'm convinced the share price is being played, but I'm not sure how. I did suspect shorting activity but I'm not so sure now. If someone had bought a million shares when they were 4p they would be sitting on a vast profit. They could easily sell chunks of 10,000 to force the price down (which is definitely happening) and then buy back smaller amounts at the lower prices, maybe regaining 75% of their holding but 10% cheaper than they sold. They may even be shorting the stock at the same time they are selling! With a million shares you could easily keep that up for 2 years, cash in your gigantic profit from the original purchases and continue to make money on the peaks and troughs. This is an illiquid share with only 78 million in circulation, and a high proportion are owned by directors and private investors holding out for free SBTX:SkinBiotherapeutics shares - it's a perfect share to trade in this way.
At some point they will run out of shares, or the momentum will overtake them. Now I'm hoping this will be a few months away, as I have a pension transfer pot on the way. I'm almost tempted to take my 245% IQE:IQE profit and put it into here at these prices! Maybe not.
There wasn't wall-to-wall gloom this week. There were some good news stories that helped mitigate the impact of the big drops.
CAML:Central Asia Metals climbed another 7% and is now 72% up and performing wonderfully.
MTFB:Motif Bio has reversed recent declines, buoyed by the news that AMP:Amphion Innovations have re-structured their loan facility and won't be forced to offload their shares to pay it back. That threat has been weighing heavy on the shares for a while. They climbed by 9% this week and are now 20% up.
Share of the Week is KIBO:Kibo Mining which has been desperate lately, but climbed 15% this week. I am still losing 28% but there should be a massive re-rate in the new year when the Power Purchase Agreement is signed and things can start moving on the power station.
Ouch!
The ISA and share portfolios looks like this
| Weekly Change | |||
| Cash | £36.20 | -£30.00 | |
| Portfolio cost | £44,981.97 | +£0 | |
| Portfolio sell value (bid price - commission) | £44.477.55 | (-1.1%) | -£853.04 |
| Potential profits | £7,742.46 | -£711.04 | |
| Yr 3 Dividends | £34.11 | +£0 | |
| Yr 3 Profit from sales | £1,131.66 | +£0 | |
| Yr 3 Average monthly cash profit | £239.58 | (6.4%) | -£12.61 |
| Total Dividends | £1,213.16 | +£0 | |
| Total Profit from sales | £7,844.16 | +£0 | |
| Average monthly cash profit | £312.31 | (8.3%) | -£2.54 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash is down by £30 as I transferred it to the SIPP to cover charges. Portfolio value was hammered by £853 and this account is now £504 in the red. Merry bloody Christmas!
It looks like the lines have met rather than crossed, so maybe I can pretend I'm still in the black - until next week no doubt!
The SIPP looks like this after week 108
| Weekly Change | |||
| Cash | £38.66 | +£30.00 | |
| Portfolio cost | £26,007.03 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,427.93 | (5.5%) | -£255.99 |
| Potential profits | £3,940.38 | +£127.68 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £0 | +£0 | |
| Yr 3 Average monthly cash profit | £-11.54 | (-0.5%) | +£3.84 |
| Total Dividends | £916.10 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £388.51 | (17.9%) | -£3.63 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash up by the £30 transfer, potential profits up thanks to CAML:Central Asia Metals being so wonderful, but deepening losses on OPTI:Optibiotix had no problem wiping out the gains causing a £255 drop in value. Year 3 performance will be quite bad until I sell something, as the monthly charges are quite high now. While we're in negative territory the performance will improve each month - until the next charge!
Should I be getting alarmed yet?
The trading account looks like this after week 74
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £260.49 | (-46.4%) | +£2.78 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.27 | (-3.1%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Back to where it was the week before
Pleh!
So it's rather a gloomy end to the year, but I'm absolutely confident that my major holdings have massive potential for growth in 2018. Although the current situation is depressing, it could very easily turn around within a few weeks of 2018, as it did in the autumn when my portfolios soared into the black for the first time in 2 years.
Even my micro shares are on the cusp of really exciting progress. Some have been stagnating for 2 years and are hurting my portfolio badly. JLP:Jubilee Metals losing £939, KIBO:Kibo Mining losing £747, SBTX:SkinBiotherapeutics losing £409, ARL:Atlantis Resources losing £319, TRX:Tissue Regenix losing £1,107 and most of all OPTI:Optibiotix losing £3,237 but with so much to come!
Let's end the year on a positive. CAML:Central Asia Metals has gone from strength to strength and is now up by £3,338 with £647 dividends, LGEN:Legal & General continues to tick up slowly and is making £529 plus great dividends of £147 and IQE:IQE despite the recent fall is up by £6,901 and showing signs of a rapid recovery when the massive short positions are closed.
So all in all I'm in a far better position than I was 12 months ago. My combined portfolio value was £54,542 then and it's £72,165 now, which is £17,623 more. Although some of that came from top-ups, a lot came from shares increasing in value. My portfolios were in the red by £3,735 whereas this year they're in the black by £692, so there is plenty to be happy about.
Roll on 2018...
No comments:
Post a Comment